The high price tag for a new Alzheimer’s drug has fueled the ongoing drug price debate. But will patients really pay sticker price? (Spoiler alert: No!).
Co-host Dr. Bob Goldberg explains the research/value assessment of the drug, while Host Terry Wilcox discusses the growing barriers to access the drug even as health networks refuse to offer it and the Institute for Clinical and Economic Review (ICER) decides to ignore its benefits.
Hear from UsAgainstAlzheimer’s COO Russ Paulsen about this breakthrough and what it means for the community, particularly minority populations. Also, against a backdrop of debates over high health care and prescription drug costs, Dr. Mark Fendrick and Dr. Jon Schommer take time to explain the problems they see affecting patients.
Terry Wilcox, Executive Director, Patients Rising
Dr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public Interest
Kate Pecora, Field Correspondent, Patients Rising
Russ Paulsen, COO, UsAgainstAlzheimer’s
Mark Fendrick, MD, Director, University of Michigan’s Center for Value-Based Insurance Design
Jon Schommer, PharmD, Professor, University of Minnesota College of Pharmacy
Myisha Malone King, Patient Advocate
Adam Johnson, Patient Correspondent
As COVID-19 wanes, the Alzheimer’s epidemic is just beginning
Dr. Mark Fendrick: Policies to Increase Access and Affordability to Essential Medical Care
National Health Issues Survey Results: Access and Affordability
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: firstname.lastname@example.org
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.
Ahead of Rare Disease Day, Congresswoman Cathy McMorris Rodgers (WA-05) joins the podcast to discuss new legislation that would ban the use of a discriminatory health care metric, quality adjusted life year, or QALY. Learn ho...
Stephen Kay took a job 10 hours away from his wife. Why? Because he needed insurance that would cover the costs of her multiple sclerosis care. While she had Medicare before turning 65, she was unable to purchase a supplement...
Is the cost of your health care going up? Have you struggled to access the care your doctor recommends? A group of physicians and health care experts are working to address these growing problems and make care patient-centere...